AstraZeneca PLC
1580,50
07-февраля-25 02:10:30
15 мин. задержка
Акции
-32,50
-2,01%
Сегодняшний диапазон
1575,00 - 1584,00
ISIN
N/A
Источник
Cboe
- Котировки
- Графики
Новости
- Статистика
-
AstraZeneca sheds £15 billion of market cap as weight-loss-pill data underwhelms investors
21 дек 2023 19:44:53 Источник MarketWatch
-
AstraZeneca Will Acquire RSV Vaccine Developer Icosavax For $1.1 Billion
12 дек 2023 03:30:35 Источник Forbes - World
-
AstraZeneca To Buy US-based Icosavax In Around $1.1 Bln Deal
12 дек 2023 02:42:28 Источник NASDAQ US Markets
-
AstraZeneca : Phase III Trial Data Show Danicopan Sustained Clinical Improvements In PNH
10 дек 2023 22:22:28 Источник NASDAQ US Markets
-
AstraZeneca Just Joined the AI Drug Development Craze, but Is It a Buy in 2024?
10 дек 2023 08:09:34 Источник NASDAQ US Markets
-
Is Now the Right Time to Buy AstraZeneca Stock?
10 дек 2023 06:46:15 Источник NASDAQ US Markets
-
Absci (ABSI) Up on AstraZeneca Deal to Design New Cancer Therapy
05 дек 2023 08:27:21 Источник NASDAQ Stocks
-
Absci, AstraZeneca Join To Deliver AI-designed Antibody Against Oncology Target
04 дек 2023 07:12:31 Источник NASDAQ US Markets
-
AstraZeneca To Discontine STABILIZE-CKD, DIALIZE-Outcomes Trials Under CRYSTALIZE Programme
01 дек 2023 01:39:09 Источник NASDAQ US Markets
-
AstraZeneca Launches Evinova Healthtech Business
20 ноя 2023 08:21:15 Источник NASDAQ US Markets
-
Pharma Stock Roundup: FDA Okays AZN's Capivasertib & MRK's Keytruda Expanded Use
17 ноя 2023 08:20:24 Источник NASDAQ Stocks
-
AstraZeneca: Truqap Plus Faslodex Approved In US For HR+ Breast Cancer
17 ноя 2023 02:04:07 Источник NASDAQ US Markets
-
Interesting AZN Put And Call Options For July 2024
16 ноя 2023 10:57:01 Источник NASDAQ Stocks
-
AstraZeneca : Phase III Trial Of Imfinzi + Chemoradiotherapy In Lung Cancer Fails To Meet Main Goal
14 ноя 2023 02:55:47 Источник NASDAQ US Markets
-
AstraZeneca (AZN) Beats on Q3 Earnings & Sales, Ups 2023 View
10 ноя 2023 08:14:44 Источник NASDAQ Stocks
-
AstraZeneca Plc (AZN) Q3 2023 Earnings Call Transcript
09 ноя 2023 17:26:41 Источник NASDAQ US Markets
-
AstraZeneca Paying Up To $2 Billion For Experimental Obesity Pill—As Weight Loss Drug Market Grows
09 ноя 2023 08:57:51 Источник Forbes - World
-
09 ноя 2023 05:19:20 Источник MarketWatch
-
09 ноя 2023 04:10:57 Источник MarketWatch
-
AstraZeneca Reaches Obesity Drug Deal; Imfinzi Combination Meets Main Goal In Liver Cancer Trial
09 ноя 2023 02:55:26 Источник NASDAQ US Markets